Buscador de publicaciones

Publicaciones

  • Ciruela Navas P, Soldevila N, Selva L, Hernández S, García-García JJ, Fernando Moraga Llop, Fernández de Sevilla-Estrach M, Codina MG, Ana Maria Planes Reig, Esteva-Afonso C, Coll F, Cardeñosa N, Jordán-García I, Batalla J, Salleras L, Munoz-Almagro C and Domínguez A.

    Are risk factors associated with invasive pneumococcal disease according to different serotypes?

    Human Vaccines & Immunotherapeutics . 9(3): 712-719. Nº de citas: 7

    [doi:10.4161/hv.23270]

  • Hernández-Bou S, García-García JJ, Gene-Giralt A, Esteva-Afonso C, del Amo-Morán E and Munoz-Almagro C.

    Pneumococcal carriage in children attending a hospital outpatient clinic in the era of pneumococcal conjugate vaccines in Barcelona

    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE . 74(3): 258-262. Nº de citas: 8

    [doi:10.1016/j.diagmicrobio.2012.07.005]

  • Selva L, Ciruela Navas P, Esteva-Afonso C, Fernández de Sevilla-Estrach M, Codina MG, Hernández-Bou S, Fernando Moraga Llop, García-García JJ, Ana Maria Planes Reig, Coll F, Jordán-García I, Cardeñosa N, Batalla J, Salleras L, Dominguez A and Munoz-Almagro C.

    Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR

    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES . 31(7): 1487-1495. Nº de citas: 37

    [doi:10.1007/s10096-011-1468-7]

  • Fernández de Sevilla-Estrach M, García-García JJ, Esteva-Afonso C, Fernando Moraga Llop, Hernández S, Selva L, Coll F, Ciruela Navas P, Ana Maria Planes Reig, Codina MG, Salleras L, Jordán-García I, Domínguez A and Munoz-Almagro C.

    Clinical Presentation of Invasive Pneumococcal Disease in Spain in the Era of Heptavalent Conjugate Vaccine

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 31(2): 124-128. Nº de citas: 24

    [doi:10.1097/INF.0b013e318241d09e]

  • Úbeda-Paez, I, Díaz Conradi, A, Selva L, Esteva-Afonso C, Munoz-Almagro C and Urraca Martínez, O.

    Bacteriemia neumocócica durante el año 2009 en un hospital pediátrico de nivel 2: características clínicas y microbiológicas

    Acta Pediátrica Española . 70(6): 147-150.

  • Domínguez A, Ciruela Navas P, García-García JJ, Fernando Moraga Llop, Fernández de Sevilla-Estrach M, Selva L, Coll F, Munoz-Almagro C, Ana Maria Planes Reig, Codina MG, Jordán-García I, Esteva-Afonso C, Hernández S, Soldevila N, Cardeñosa N, Batalla J and Salleras L.

    Effectiveness of 7-valent pneumococcal conjugate vaccine in the prevention of invasive pneumococcal disease in children aged 7-59 months. A matched case-control study

    Vaccine . 29(48): 9020-9025. Nº de citas: 20

    [doi:10.1016/j.vaccine.2011.09.034]

  • Esteva-Afonso C, Selva L, Fernández de Sevilla-Estrach M, García-García JJ, Pallares R and Munoz-Almagro C.

    Streptococcus pneumoniae serotype 1 causing invasive disease among children in Barcelona over a 20-year period (1989-2008)

    CLINICAL MICROBIOLOGY AND INFECTION . 17(9): 1441-1444. Nº de citas: 14

    [doi:10.1111/j.1469-0691.2011.03526.x]

  • Claret-Teruel G, Noguera-Julian A, Esteva-Afonso C, Munoz-Almagro C, Sánchez E, Jiménez R and Fortuny-Guasch C.

    IMPACT OF HUMAN IMMUNODEFICIENCY VIRUS COINFECTION ON THE PROGRESSION OF MOTHER-TO-CHILD TRANSMITTED HEPATITIS C VIRUS INFECTION

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 30(9): 801-804. Nº de citas: 10

    [doi:10.1097/INF.0b013e3182196ab4]

  • Munoz-Almagro C, Ciruela Navas P, Esteva-Afonso C, Marco F, Navarro M, Bartolome R, Sauca G, Gallés C, Morta M, Ballester F, Raga X and Selva L.

    Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain

    JOURNAL OF INFECTION . 63(2): 151-162. Nº de citas: 41

    [doi:10.1016/j.jinf.2011.06.002]

  • Munoz-Almagro C, Selva L, Sanchez CJ, Esteva-Afonso C, Fernández de Sevilla-Estrach M, Pallares R and Orihuela CJ.

    PsrP, a Protective Pneumococcal Antigen, Is Highly Prevalent in Children with Pneumonia and Is Strongly Associated with Clonal Type

    CLINICAL AND VACCINE IMMUNOLOGY . 17(11): 1672-1678. Nº de citas: 26

    [doi:10.1128/CVI.00271-10]